Tag: Crohn’s Disease
Prevalence of Primary Sclerosing Cholangitis in IBD Explored
Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease is about 2 percent
Intestinal Ultrasound Informs Management of IBD
In 60 percent of patients, IUS had impact on disease management, with change in medication in 47.8 percent
FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases
Cyltezo is first interchangeable monoclonal antibody for RA, psoriatic arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, chronic plaque psoriasis
Prevalence of Primary Sclerosing Cholangitis in IBD Examined
Global prevalence of primary sclerosing cholangitis ranges from 0.96 percent in Crohn disease to 2.47 percent in ulcerative colitis
Outcome Measure Developed for Crohn’s Perianal Fistula
Crohn's Anal Fistula QoL has good internal consistency, excellent stability, good responsiveness and construct validity
Diets Compared for Mild-to-Moderate Crohn Disease in Adults
Rate of symptomatic remission at week 6 similar for Mediterranean diet, specific carbohydrate diet in randomized trial
2001 to 2018 Saw Increase in Estimated Prevalence of IBD in Seniors
Increase higher among non-Hispanic Blacks, while prevalence was consistently highest for non-Hispanic Whites
Crohn Disease, Comorbidities Up Risk for Severe Pneumococcal Disease
Receipt of PCV13 alone or in combination with PPSV23 predicts fivefold reduced risk for SPD compared with no vaccination
Inflammatory Bowel Disease Tied to Subsequent Rhinosinusitis
